カテゴリ： MarketLine, アメリカ, 企業調査

Acorda Therapeutics, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4632
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acorda Therapeutics (Acorda or ‘the company’) is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda’s product portfolio are marketed under Zanaflex, Ampyra or Fampyra (dalfampridine); and Qutenza.The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Acorda Therapeutics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Acorda Therapeutics, Inc.: Company Overview
Acorda Therapeutics, Inc.: Overview and Key Facts
Acorda Therapeutics, Inc.: Overview
Acorda Therapeutics, Inc.: Key Facts
Acorda Therapeutics, Inc.: Key Employees
Acorda Therapeutics, Inc.: Key Employee Biographies
Acorda Therapeutics, Inc.: Major Products and Services
Acorda Therapeutics, Inc.: Company History
Acorda Therapeutics, Inc.: Management Statement
Acorda Therapeutics, Inc.: Locations and Subsidiaries
Acorda Therapeutics, Inc.: Key Competitors
Acorda Therapeutics, Inc.: Company Analysis
Acorda Therapeutics, Inc.: Business Description
Acorda Therapeutics, Inc.: SWOT Analysis
Acorda Therapeutics, Inc.: SWOT Overview
Acorda Therapeutics, Inc.: Strengths
Acorda Therapeutics, Inc.: Weaknesses
Acorda Therapeutics, Inc.: Opportunities
Acorda Therapeutics, Inc.: Threats
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity
Acorda Therapeutics, Inc.: Financial Deals Overview
Acorda Therapeutics, Inc.: Targets and Partners
Acorda Therapeutics, Inc.: Top Deals 2016 – 2020YTD*
Acorda Therapeutics, Inc.: Advisors
Acorda Therapeutics, Inc.: Top Legal Advisors
Acorda Therapeutics, Inc.: Top Financial Advisors
Acorda Therapeutics, Inc.: Mergers and Acquisitions
Acorda Therapeutics, Inc.: Divestments
Acorda Therapeutics, Inc.: Private Equity and Ownership
Acorda Therapeutics, Inc.: Recent Developments
Acorda Therapeutics, Inc.: News and Events Summary
Acorda Therapeutics, Inc.: Business Reorganization
Acorda Therapeutics, Inc.: Contracts
Acorda Therapeutics, Inc.: Corporate Governance
Acorda Therapeutics, Inc.: Financial Performance
Acorda Therapeutics, Inc.: Market Developments
Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Acorda Therapeutics, Inc.: Regulatory and Legal Events
Acorda Therapeutics, Inc.: Research & Development
Acorda Therapeutics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Company History
Table 4: Acorda Therapeutics, Inc.: Locations and Subsidiaries
Table 5: Acorda Therapeutics, Inc.: Key Competitors
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 16: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 17: Acorda Therapeutics, Inc.: News and Events Summary
Table 18: Acorda Therapeutics, Inc.: Business Reorganization
Table 19: Acorda Therapeutics, Inc.: Contracts
Table 20: Acorda Therapeutics, Inc.: Corporate Governance
Table 21: Acorda Therapeutics, Inc.: Financial Performance
Table 22: Acorda Therapeutics, Inc.: Market Developments
Table 23: Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Table 24: Acorda Therapeutics, Inc.: Regulatory and Legal Events
Table 25: Acorda Therapeutics, Inc.: Research & Development
Table 26: Acorda Therapeutics, Inc.: Strategy and Operations

★海外企業調査レポート[Acorda Therapeutics, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Karambunai Corporation Berhad：戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BrainLAB AG：医療機器：M&Aディール及び事業提携情報
    Summary BrainLAB AG (Brainlab) is a medical technology company that develops, manufactures and markets medical technology facilitated by software that helps optimize treatment outcomes. The company provides technological solutions in radiosurgery and numerous surgical fields such as neurosurgery, or …
  • Onorach Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Onorach Ltd (Onorach) is a contract research organization that provides clinical support services. The organization service portfolio includes tailored clinical trial support, clinical plan development, protocol design, regulatory, quality management, clinical operations management, patient …
  • Cerus Energy Group Ltd (CEA)：石油・ガス：M&Aディール及び事業提携情報
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Sky plc：企業のM&A・事業提携・投資動向
    Sky plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sky plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Lay Hong Berhad (LAYHONG)：企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Shutterfly Inc：企業の戦略的SWOT分析
    Shutterfly Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Marine Harvest ASA：企業のM&A・事業提携・投資動向
    Marine Harvest ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marine Harvest ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bristol-Myers Squibb Company：企業の戦略・SWOT・財務情報
    Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report Summary Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Laboratory Corporation of America Holdings：企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Toyota Industries Corp (6201)：企業の財務・戦略的SWOT分析
    Toyota Industries Corp (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cadila Healthcare Ltd (CADILAHC)：企業の財務・戦略的SWOT分析
    Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Petrolina (Holdings) Public Ltd (PHL)：企業の財務・戦略的SWOT分析
    Petrolina (Holdings) Public Ltd (PHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • RPC Group Plc (RPC)：企業の財務・戦略的SWOT分析
    RPC Group Plc (RPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Netflix Inc (NFLX)：企業の財務・戦略的SWOT分析
    Netflix Inc (NFLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Keysight Technologies Inc：戦略・SWOT・企業財務分析
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Central Foods Ltd：企業の戦略・SWOT・財務分析
    Central Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Baumot Group AG (TINC)：企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Okinawa Electric Power Company Incorporated (9511)：企業の財務・戦略的SWOT分析
    Okinawa Electric Power Company Incorporated (9511) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • CellSeed Inc (7776)：製薬・医療：M&Aディール及び事業提携情報
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆